title: Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes.
abstract: De novo mutations affect risk for many diseases and disorders, especially those with early-onset. An example is autism spectrum disorders (ASD). Four recent whole-exome sequencing (WES) studies of ASD families revealed a handful of novel risk genes, based on independent de novo loss-of-function (LoF) mutations falling in the same gene, and found that de novo LoF mutations occurred at a twofold higher rate than expected by chance. However successful these studies were, they used only a small fraction of the data, excluding other types of de novo mutations and inherited rare variants. Moreover, such analyses cannot readily incorporate data from case-control studies. An important research challenge in gene discovery, therefore, is to develop statistical methods that accommodate a broader class of rare variation. We develop methods that can incorporate WES data regarding de novo mutations, inherited variants present, and variants identified within cases and controls. TADA, for Transmission And De novo Association, integrates these data by a gene-based likelihood model involving parameters for allele frequencies and gene-specific penetrances. Inference is based on a Hierarchical Bayes strategy that borrows information across all genes to infer parameters that would be difficult to estimate for individual genes. In addition to theoretical development we validated TADA using realistic simulations mimicking rare, large-effect mutations affecting risk for ASD and show it has dramatically better power than other common methods of analysis. Thus TADA's integration of various kinds of WES data can be a highly effective means of identifying novel risk genes. Indeed, application of TADA to WES data from subjects with ASD and their families, as well as from a study of ASD subjects and controls, revealed several novel and promising ASD candidate genes with strong statistical support.
authors: Lane Center of Computational Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania, United States of America.
authors: Xin
authors: X
authors: He
authors: Stephan J
authors: SJ
authors: Sanders
authors: Li
authors: L
authors: Liu
authors: Silvia
authors: S
authors: De Rubeis
authors: Elaine T
authors: ET
authors: Lim
authors: James S
authors: JS
authors: Sutcliffe
authors: Gerard D
authors: GD
authors: Schellenberg
authors: Richard A
authors: RA
authors: Gibbs
authors: Mark J
authors: MJ
authors: Daly
authors: Joseph D
authors: JD
authors: Buxbaum
authors: Matthew W
authors: MW
authors: State
authors: Bernie
authors: B
authors: Devlin
authors: Kathryn
authors: K
authors: Roeder
mesh_terms: D001499:Bayes Theorem; D016022:Case-Control Studies; D002659:Child Development Disorders, Pervasive / Q000235:genetics*; D059472:Exome; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D016013:Likelihood Functions; D008962:Models, Theoretical; D009154:Mutation; D012307:Risk Factors; D017422:Sequence Analysis, DNA
references: Neuron. 2011 Jun 9;70(5):863-85
references: 21658581
references: Genet Epidemiol. 2012 Jul;36(5):488-98
references: 22628073
references: Biol Psychiatry. 2012 Apr 15;71(8):733-40
references: 22297151
references: Mol Cell Biol. 2011 Jan;31(2):238-47
references: 21059867
references: Genes Dev. 2010 Jan 15;24(2):206-18
references: 20080956
references: J Cell Biol. 2011 Jun 13;193(6):985-94
references: 21670212
references: PLoS One. 2012;7(2):e30643
references: 22363459
references: Neuron. 2012 Apr 26;74(2):285-99
references: 22542183
references: Science. 2012 Dec 21;338(6114):1619-22
references: 23160955
references: Science. 2012 Jul 6;337(6090):64-9
references: 22604720
references: J Neurosci. 2003 Jan 1;23(1):203-12
references: 12514217
references: Neuron. 2013 Jan 23;77(2):235-42
references: 23352160
references: J Neurosci. 2012 Jun 13;32(24):8219-30
references: 22699903
references: Nature. 2012 Apr 04;485(7397):246-50
references: 22495309
references: Am J Hum Genet. 2012 Jan 13;90(1):7-24
references: 22243964
references: Mol Biol Cell. 2006 Mar;17(3):1250-60
references: 16394099
references: Nature. 2012 Apr 04;485(7397):242-5
references: 22495311
references: PLoS Genet. 2012;8(4):e1002635
references: 22511880
references: Neuron. 2011 Jun 9;70(5):886-97
references: 21658582
references: PLoS Genet. 2013 Apr;9(4):e1003443
references: 23593035
references: Nat Rev Genet. 2010 Nov;11(11):773-85
references: 20940738
references: Brain Res. 2011 Mar 22;1380:78-84
references: 21078308
references: Oncogene. 2012 Nov 1;31(44):4709-17
references: 22249253
references: Neurogenetics. 2010 Feb;11(1):41-52
references: 19548013
references: Nat Genet. 2012 May 29;44(6):623-30
references: 22641211
references: Nat Rev Genet. 2012 Jul 18;13(8):565-75
references: 22805709
references: Nature. 2010 Jul 15;466(7304):368-72
references: 20531469
references: Am J Hum Genet. 2001 Jul;69(1):124-37
references: 11404818
references: Nature. 2012 Aug 23;488(7412):471-5
references: 22914163
references: Nat Genet. 2011 Jun;43(6):585-9
references: 21572417
references: Biometrics. 1999 Dec;55(4):997-1004
references: 11315092
references: Mol Autism. 2012 Oct 15;3(1):9
references: 23067556
references: Nat Methods. 2010 Apr;7(4):248-9
references: 20354512
references: Hum Mol Genet. 2010 Oct 15;19(20):4072-82
references: 20663923
references: Am J Hum Genet. 2001 Aug;69(2):371-80
references: 11443542
references: J Clin Invest. 2010 Jul;120(7):2446-56
references: 20516644
references: Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13129-34
references: 20615956
references: Nature. 2012 Apr 04;485(7397):237-41
references: 22495306
references: Nat Rev Genet. 2010 Oct;11(10):733-9
references: 20838408